ASSOCIATIONS OF ORAL-CONTRACEPTIVE USE WITH SERUM-LIPIDS AND LIPOPROTEINS IN YOUNG-WOMEN - THE BOGALUSA HEART-STUDY

Citation
Kj. Greenlund et al., ASSOCIATIONS OF ORAL-CONTRACEPTIVE USE WITH SERUM-LIPIDS AND LIPOPROTEINS IN YOUNG-WOMEN - THE BOGALUSA HEART-STUDY, Annals of epidemiology, 7(8), 1997, pp. 561-567
Citations number
27
Journal title
ISSN journal
10472797
Volume
7
Issue
8
Year of publication
1997
Pages
561 - 567
Database
ISI
SICI code
1047-2797(1997)7:8<561:AOOUWS>2.0.ZU;2-2
Abstract
PURPOSE: Cross-sectional and longitudinal associations of serum lipids and lipoproteins with oral contraceptive (OC) use were examined among white and black women aged 18-27 years in 1985-86 and 1988-1991 in th e Bogalusa Heart Study, a study of cardiovascular disease in a Souther n community. METHODS: Analyses of covariance. RESULTS: In 1985-1986, w hite OC users had significantly (p < 0.05) higher adjusted mean total and low density lipoprotein (LDL) cholesterols, and lower high density lipoprotein (HDL) cholesterol compared with nonusers; black OC users had higher triglycerides and LDL cholesterol, and lower HDL cholestero l. In 1988-1991, white OC users bad higher total cholesterol, triglyce rides, and LDL cholesterol, while black OC users had higher triglyceri des. OC use was unrelated to mean HDL cholesterol levels in 1988-1991; however, a lower percentage of white OC users than nonusers in 1988-1 991 had HDL cholesterol levels < 35 mg/dl. Longitudinally, white OC no nusers at baseline who used OCs at follow up had significant increases from baseline levels in total cholesterol, triglycerides, and very lo w density lipoprotein (VLDL) and LDL cholesterols; black women showed an increase only in LDL cholesterol. White women who stopped using OCs by follow-up had a decrease in VLDL and LDL cholesterols, and an incr ease in HDL cholesterol. White OC users at both exams also had a signi ficant increase in HDL cholesterol, whereas women who began using OCs by follow-up did not. CONCLUSIONS: The unfavorable lipid profile assoc iated with OC use was not apparent upon discontinued use. Lack of an a dverse effect of OC use on HDL cholesterol at follow-up may be the res ult of changing formulations, and requires further examination. (C) 19 97 Elsevier Science Inc.